Literature DB >> 22552582

Green tea polyphenols increase p53 transcriptional activity and acetylation by suppressing class I histone deacetylases.

Vijay S Thakur1, Karishma Gupta, Sanjay Gupta.   

Abstract

Acetylation of the tumor suppressor gene p53 at the carboxy-terminal lysine (Lys) residues enhances its transcriptional activity associated with cell cycle arrest and apoptosis. Histone deacetylases (HDACs), a family of evolutionarily conserved enzymes, counterbalance the acetylation of lysine residues on histone and non-histone proteins. In this study, we demonstrate that green tea polyphenols (GTPs) and their major constituent, (-) epigallocatechin-3-gallate (EGCG), activate p53 through acetylation at the Lys373 and Lys382 residues by inhibiting class I HDACs in LNCaP human prostate cancer cells. Treatment of cells with GTPs (2.5-10 µg/ml) and EGCG (5-20 µM) resulted in dose- and time-dependent inhibition of class I HDACs (HDAC1, 2, 3 and 8), albeit at varying levels. Discontinuation of treatment with GTP/EGCG resulted in the loss of p53 acetylation at both the sites in these cells. GTP/EGCG treatment also resulted in increased expression of p21/waf1 and Bax at the protein and message levels in these cells. The increased GTP/EGCG-mediated p53 acetylation enhanced its binding on the promoters of p21/waf1 and Bax, which was associated with increased accumulation of cells in the G0/G1 phase of the cell cycle and induction of apoptosis. Our findings indicate that GTP/EGCG causes acetylation of p53 by inhibiting class I HDACs, a function that is likely to be part of the mechanisms that control the physiological activity of p53.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22552582      PMCID: PMC3580388          DOI: 10.3892/ijo.2012.1449

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  37 in total

1.  p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2.

Authors:  A Ito; C H Lai; X Zhao; S Saito; M H Hamilton; E Appella; T P Yao
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

2.  PML regulates p53 acetylation and premature senescence induced by oncogenic Ras.

Authors:  M Pearson; R Carbone; C Sebastiani; M Cioce; M Fagioli; S Saito; Y Higashimoto; E Appella; S Minucci; P P Pandolfi; P G Pelicci
Journal:  Nature       Date:  2000-07-13       Impact factor: 49.962

3.  Acetylation of p53 inhibits its ubiquitination by Mdm2.

Authors:  Muyang Li; Jianyuan Luo; Christopher L Brooks; Wei Gu
Journal:  J Biol Chem       Date:  2002-11-05       Impact factor: 5.157

4.  Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo.

Authors:  D M Vigushin; S Ali; P E Pace; N Mirsaidi; K Ito; I Adcock; R C Coombes
Journal:  Clin Cancer Res       Date:  2001-04       Impact factor: 12.531

5.  Histone deacetylases specifically down-regulate p53-dependent gene activation.

Authors:  L J Juan; W J Shia; M H Chen; W M Yang; E Seto; Y S Lin; C W Wu
Journal:  J Biol Chem       Date:  2000-07-07       Impact factor: 5.157

6.  Mechanism of cell cycle arrest caused by histone deacetylase inhibitors in human carcinoma cells.

Authors:  Y B Kim; S W Ki; M Yoshida; S Horinouchi
Journal:  J Antibiot (Tokyo)       Date:  2000-10       Impact factor: 2.649

7.  MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation.

Authors:  Akihiro Ito; Yoshiharu Kawaguchi; Chun-Hsiang Lai; Jeffrey J Kovacs; Yuichiro Higashimoto; Ettore Appella; Tso-Pang Yao
Journal:  EMBO J       Date:  2002-11-15       Impact factor: 11.598

8.  The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene.

Authors:  Gerda Lagger; Angelika Doetzlhofer; Bernd Schuettengruber; Eva Haidweger; Elisabeth Simboeck; Julia Tischler; Susanna Chiocca; Guntram Suske; Hans Rotheneder; Erhard Wintersberger; Christian Seiser
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

9.  Chemoprevention of carcinogen-induced mammary tumorigenesis by the hybrid polar cytodifferentiation agent, suberanilohydroxamic acid (SAHA).

Authors:  L A Cohen; S Amin; P A Marks; R A Rifkind; D Desai; V M Richon
Journal:  Anticancer Res       Date:  1999 Nov-Dec       Impact factor: 2.480

10.  ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways.

Authors:  Y Zhang; Y Xiong; W G Yarbrough
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

View more
  37 in total

1.  EGCG prevents PCB-126-induced endothelial cell inflammation via epigenetic modifications of NF-κB target genes in human endothelial cells.

Authors:  Dandan Liu; Jordan T Perkins; Bernhard Hennig
Journal:  J Nutr Biochem       Date:  2015-10-26       Impact factor: 6.048

Review 2.  Apoptosis and autophagy induction as mechanism of cancer prevention by naturally occurring dietary agents.

Authors:  Eiman Mukhtar; Vaqar Mustafa Adhami; Naghma Khan; Hasan Mukhtar
Journal:  Curr Drug Targets       Date:  2012-12       Impact factor: 3.465

3.  Effects of Tea Catechins on Cancer Signaling Pathways.

Authors:  Chung S Yang; Hong Wang; Jayson X Chen; Jinsong Zhang
Journal:  Enzymes       Date:  2014

Review 4.  Impact of Epigenetic Dietary Components on Cancer through Histone Modifications.

Authors:  Yifeng Gao; Trygve O Tollefsbol
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

5.  Regulation of p53-targeting microRNAs by polycyclic aromatic hydrocarbons: Implications in the etiology of multiple myeloma.

Authors:  Michael W Gordon; Fang Yan; Xiaoming Zhong; Pranab Behari Mazumder; Zijun Y Xu-Monette; Dehui Zou; Ken H Young; Kenneth S Ramos; Yong Li
Journal:  Mol Carcinog       Date:  2014-05-06       Impact factor: 4.784

6.  Green tea polyphenol epigallocatechin 3-gallate, contributes to the degradation of DNMT3A and HDAC3 in HCT 116 human colon cancer cells.

Authors:  Vondina R Moseley; Jay Morris; Rebecca W Knackstedt; Michael J Wargovich
Journal:  Anticancer Res       Date:  2013-12       Impact factor: 2.480

Review 7.  Histone and Non-Histone Targets of Dietary Deacetylase Inhibitors.

Authors:  Eunah Kim; William H Bisson; Christiane V Löhr; David E Williams; Emily Ho; Roderick H Dashwood; Praveen Rajendran
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

Review 8.  Natural compound-derived epigenetic regulators targeting epigenetic readers, writers and erasers.

Authors:  Anne Yuqing Yang; Hyuck Kim; Wenji Li; Ah-Ng Tony Kong
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

Review 9.  Medicinal chemistry of the epigenetic diet and caloric restriction.

Authors:  S L Martin; T M Hardy; T O Tollefsbol
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

10.  Possible Loss of GABAergic Inhibition in Mice With Induced Adenomyosis and Treatment With Epigallocatechin-3-Gallate Attenuates the Loss With Improved Hyperalgesia.

Authors:  Yumei Chen; Bo Zhu; Hongping Zhang; Ding Ding; Xishi Liu; Sun-Wei Guo
Journal:  Reprod Sci       Date:  2014-02-03       Impact factor: 3.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.